Life sciences companies have an opportunity to build markets and categories for new medicines that promise better efficacy, safety, value and price. At the proof-of-concept stage, smart startups begin to shape markets in advance of regulatory approval, which has the potential to increase their companies’ value.
In this program, Donna LaVoie, president and CEO of LaVoieHealthScience, will help innovators expand their thinking beyond the next fund-raise and build longer-term value for stakeholders. Listen to two case studies of companies that invested in advance of product marketing, clearance and launch.
You will learn:
- At what company stage to begin thinking about market shaping
- Strategies and tactics to lay the foundation for shifting perceptions ahead of the pre-commercial launch
- Which stakeholders to involve in market shaping activities
- How to measure the impact of market-shaping activities